Panacea Biotec Limited Bombay S.E.

PANACEABIO

INE922B01023

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-04-25 am EDT			5-day change	1st Jan Change
146.2 ^INR	+2.92%		+6.41%	-13.03%

Apr. 13	Panacea Biotec Limited Appoints Ambika Sharma as Non-Executive Independent Director	CI
Apr. 01	Panacea Biotec Limited Announces the Cessation of Mr. Krishna Murari Lal, Mr. Namdeo Narayan Khamitkar and Mr. Raghava Lakshmi Narasimhan as Independent Directors	CI

Panacea Biotec Limited Announces Demise of Ashwini Luthra as Independent Director

July 13, 2021 at 07:44 am EDT

Panacea Biotec Limited announced demise of Mr. Ashwini Luthra, Independent Director of the company has departed for his heavenly abode July 13, 2021.

Latest news about Panacea Biotec Limited

Panacea Biotec Limited Appoints Ambika Sharma as Non-Executive Independent Director	Apr. 13	CI
Panacea Biotec Limited Announces the Cessation of Mr. Krishna Murari Lal, Mr. Namdeo Narayan Khamitkar and Mr. Raghava Lakshmi Narasimhan as Independent Directors	Apr. 01	CI
Panacea Biotec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Panacea Biotec Launches EasyFourPol® in India and Receives Registration of Valganciclovir Powder for Oral Solution in Germany	Dec. 14	CI
Panacea Biotec Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Panacea Biotec Launches Generic Cancer Treatment Drug in Canada	23-10-29	MT
Panacea Biotec's Arm Gets Nine Observations from US FDA	23-10-13	MT
Indian Immunologicals targets dengue vaccine launch by Jan 2026	23-08-24	RE
Panacea Biotec Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-12	CI
Panacea Biotec Launches New Pediatric Food, Nutritional Products	23-06-15	MT
Panacea Biotec Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Panacea Biotec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
Panacea Biotec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Panacea Biotec Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23-02-14	CI
Panacea Biotec Donates Pentavalent Vaccine to Cuba	23-01-17	MT
Panacea Biotec Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI

Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.

Sector

Pharmaceuticals

Calendar

2024-05-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.70%	42.78B
OTSUKA HOLDINGS CO., LTD.	+18.59%	22.25B
SANDOZ GROUP AG	+14.34%	14.39B
CIPLA LIMITED	+12.83%	13.55B
ZYDUS LIFESCIENCES LIMITED	+38.02%	11.27B
ONO PHARMACEUTICAL CO., LTD.	-9.80%	6.95B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+6.29%	5.01B